The present study suggested that CARD9 knockout may potentially ameliorate diet‐induced inflammation, insulin resistance, metabolic disorders and T2D either by inhibiting the NF‐κB and MAPKs signalling pathway or by improving insulin action and enhancing the energy metabolism. Here, NFKB1 is linked to metabolic disease.